The efficacy of tumour necrosis factor-a antagonists in maintenance therapy for ulcerative colitis

被引：0
|
作者：
Ng, Alexander [1 ]
机构：
[1] UCL, Fac Laws, Gower St, London WC1E 6BT, England
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 33卷
关键词：
D O I：
10.1097/MEG.0000000000002188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E1088 / E1088
页数：1
相关论文
共 50 条
  • [1] Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
    Feagan, Brian G.
    Rubin, David T.
    Danese, Silvio
    Vermeire, Severine
    Abhyankar, Brihad
    Sankoh, Serap
    James, Alexandra
    Smyth, Michael
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (02) : 229 - +
  • [2] A MULTINATIONAL STUDY TO DETERMINE INDICATORS OF SUBOPTIMAL THERAPY AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH TUMOUR NECROSIS FACTOR ANTAGONISTS
    Lindsay, J.
    Gisbert, J.
    Mody, R.
    Peyrin-Biroulet, L.
    Armuzzi, A.
    Bokemeyer, B.
    Nguyen, G.
    Siebenaler, J.
    Akerborg, O.
    Smyth, M.
    Rathmell, A.
    GUT, 2016, 65 : A253 - A254
  • [3] Efficacy of tumour necrosis factor-a antagonists in aphthous ulceration: review of published individual patient data
    O'Neill, I. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) : 231 - 235
  • [4] Anti-tumour necrosis factor therapy for ulcerative colitis - Evidence to date
    Thukral, Chandrashekhar
    Cheifetz, Adam
    Peppercorn, Mark A.
    DRUGS, 2006, 66 (16) : 2059 - 2065
  • [5] Comparative efficacy of anti-tumour necrosis factor agents and vedolizumab in ulcerative colitis
    Subramanian, S.
    Davis, R.
    MacParland, P.
    Dodd, S.
    Storey, D.
    Probert, C.
    Collins, P.
    Skouras, T.
    Steel, A.
    Derbyshire, E.
    Dibb, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S321 - S321
  • [6] Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis
    Su, CY
    Salzberg, BA
    Lewis, JD
    Deren, JJ
    Kornbluth, A
    Katzka, DA
    Stein, RB
    Adler, DR
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2577 - 2584
  • [7] Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials
    Lopez, Anthony
    Ford, Alexander C.
    Colombel, Jean-Frederic
    Reinisch, Walter
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (05) : 356 - 364
  • [8] C-Reactive Protein Correlates with Tumor Necrosis Factor-a in Ulcerative Colitis
    McDonagh, P.
    O'Connell, F.
    O'Connell, J.
    Argue, R.
    Corcoran, R.
    Kevans, D.
    O'Sullivan, J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S184 - S186
  • [9] The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor-α inhibitor
    Suzuki, Taketo
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Sugimura, Naomi
    Katano, Takahito
    Nishie, Hirotada
    Kataoka, Hiromi
    JGH OPEN, 2019, 3 (03): : 217 - 223
  • [10] Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis
    McDermott, Edel
    Murphy, Seamus
    Keegan, Denise
    O'Donoghue, Diarmuid
    Mulcahy, Hugh
    Doherty, Glen
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (02): : 150 - 153
12345